Elite Pharmaceuticals
Specialty pharmaceutical company developing abuse deterrent opioids and niche generics to curb misuse and abuse. Learn more
Launch date
Employees
Market cap
CAD586m
Enterprise valuation
CAD590m (Public information from Sep 2024)
Share price
$0.39 ELTP
Northvale New Jersey (HQ)
Authorizing premium user...